Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of overloading pathways on toxicity

F J Wolf

    Journal of Environmental Pathology and Toxicology
    |June 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Drug metabolism pathway overloading can alter toxicity by changing drug and metabolite levels. This impacts both the severity and type of adverse effects, influencing safety assessments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Discovery, development, and antimicrobial properties of D-4-amino-3-isoxazolidone (oxamycin), a new antibiotic produced by Streptomyces garyphalus n. sp.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Antibiotic salts of novobiocin.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Substituted sulfaquinoxalines; the isolation and synthesis of 3-hydroxy-2-sulfanilamidoquinoxaline and of related quinoxalines.

    Journal of the American Chemical Society·2010
    Same author

    Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)- 1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test.

    Mutation research·1984
    Same author

    Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine.

    Chemico-biological interactions·1984
    Same author

    Drug residue formation from ronidazole, a 5-nitroimidazole. VI. Lack of mutagenic activity of reduced metabolites and derivatives of ronidazole.

    Chemico-biological interactions·1984
    Same journal

    Health and ecological assessment of polynuclear aromatic hydrocarbons.

    Journal of environmental pathology and toxicology·1981
    Same journal

    Influence of diet on hexachlorobenzene accumulation in Osborne Mendel rats.

    Journal of environmental pathology and toxicology·1980
    Same journal

    Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17 beta-estradiol.

    Journal of environmental pathology and toxicology·1980
    Same journal

    Immunotoxicology studies of sodium arsenate-effects of exposure on tumor growth and cell-mediated tumor immunity.

    Journal of environmental pathology and toxicology·1980
    Same journal

    Immunocompetence over the lifespan of mice exposed in utero to carbofuran or diazinon: I. Changes in serum immunoglobulin concentrations.

    Journal of environmental pathology and toxicology·1980
    Same journal

    Effects of lead, cadmium and methylmercury on immunological memory.

    Journal of environmental pathology and toxicology·1980
    See all related articles

    Area of Science:

    • Pharmacology
    • Toxicology
    • Drug Metabolism

    Background:

    • Metabolic pathway overloading disrupts the dose-concentration relationship for drugs and metabolites.
    • This disruption can significantly influence both the degree and type of observed toxicity.
    • Key pathways involved include transport, binding, enzymatic transformation, and cofactor utilization.

    Purpose of the Study:

    • To explore how overloading metabolic pathways affects drug toxicity.
    • To examine the impact of altered drug and metabolite concentrations on toxicity profiles.
    • To discuss the implications for human health risk assessment of animal health products.

    Main Methods:

    • Review of existing literature and case examples.
    • Analysis of toxicity data related to overloaded metabolic pathways.

    Related Experiment Videos

  • Discussion of specific drug examples illustrating these principles.

    • Main Results:

    • Overloading transport, binding, or conjugation systems can alter toxicity severity (e.g., streptomycin, nitrofurans, bromobenzene, warfarin).
    • Altered enzymatic transformation due to overloading can change toxicity type based on administration route (e.g., Cambendazole, FANFT).
    • Disproportionate changes in drug/metabolite levels are central to altered toxicity.

    Conclusions:

    • Metabolic pathway overloading is a critical factor in predicting drug toxicity.
    • Understanding these mechanisms is essential for accurate risk assessment of drugs and residues.
    • Route of administration and individual metabolic capacities influence toxicity outcomes.